Status:
TERMINATED
Oculomotor and Spatial Cognition Deficits in Schizophrenia
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Schizophrenia
Eligibility:
All Genders
15-64 years
Phase:
NA
Brief Summary
DESCRIPTION: (Verbatim from the Applicant's Abstract) Abnormalities of eye movement control and spatial cognition are well-established deficits in schizophrenia. However, the regional disturbances in ...
Detailed Description
We will be assessing clinical symptoms and cognition before and after treatment.
Eligibility Criteria
Inclusion
- Inclusion criteria for this study are (1) able and willing to give written informed consent; (2) no contraindications to MRI (cardiac pacemaker, aneurysm clip, cochlear implants, IUD, shrapnel, history of metal fragments in eyes, neurostimulators or other metal devices, weight of 250lbs or more, claustrophobia) and (3) medically stable. Sedation will not be used for MRI studies because cooperation is essential.
Exclusion
- Any subject is excluded from the imaging studies if they have any contraindications to MRI such as cardiac pacemaker, aneurysm clip, cochlear implants, pregnancy in the later stages (because of body size and limited comfort for MRI studies), IUD, shrapnel, history of metal fragments in eyes, neurostimulators, weight of 250 lbs. or more, or claustrophobia. Individuals with mental retardation, neurologic disease or significant medical illness that might effect neuronal or vascular physiology will not be recruited.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00931996
Start Date
June 1 2009
End Date
November 1 2011
Last Update
January 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UIC Center for Cognitive Medicine
Chicago, Illinois, United States, 60612